LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

Search

Durect Corp

Fermé

0.51

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.51

Max

0.51

Chiffres clés

By Trading Economics

Employés

21

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+843.4% upside

Dividendes

By Dow Jones

Prochains Résultats

12 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-4.4M

15M

Ouverture précédente

0.51

Clôture précédente

0.51

Durect Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 mai 2025, 10:30 UTC

Actualités

Pension Funds Won't Save the Bond Market -- Heard on the Street -- WSJ

31 mai 2025, 06:30 UTC

Résultats

5 Things We've Learned From Retail Earnings -- Barrons.com

31 mai 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

30 mai 2025, 23:51 UTC

Acquisitions, Fusions, Rachats

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30 mai 2025, 21:30 UTC

Actualités

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30 mai 2025, 21:15 UTC

Actualités

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30 mai 2025, 20:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Health Care Roundup: Market Talk

30 mai 2025, 20:44 UTC

Acquisitions, Fusions, Rachats

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30 mai 2025, 20:24 UTC

Actualités

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30 mai 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

30 mai 2025, 19:44 UTC

Market Talk

Gold Breaks 4-Month Winning Streak -- Market Talk

30 mai 2025, 19:38 UTC

Market Talk

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30 mai 2025, 19:29 UTC

Résultats
Acquisitions, Fusions, Rachats

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30 mai 2025, 19:14 UTC

Market Talk

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30 mai 2025, 19:05 UTC

Market Talk

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30 mai 2025, 18:51 UTC

Market Talk

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30 mai 2025, 18:37 UTC

Market Talk
Résultats

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30 mai 2025, 18:04 UTC

Actualités

S&P 500 Falls After More Trump-China Friction -- WSJ

30 mai 2025, 17:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mai 2025, 17:47 UTC

Market Talk

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30 mai 2025, 17:40 UTC

Acquisitions, Fusions, Rachats

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30 mai 2025, 17:38 UTC

Market Talk

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30 mai 2025, 17:31 UTC

Market Talk

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30 mai 2025, 17:14 UTC

Actualités

American Consumers Are Still Gloomy on the Economy -- 3rd Update

30 mai 2025, 16:31 UTC

Résultats

Ulta Beauty Stock Is Rising. Earnings Strength Was More Than Cosmetic. -- Barrons.com

30 mai 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

30 mai 2025, 16:20 UTC

Market Talk
Acquisitions, Fusions, Rachats

Health Care Roundup: Market Talk

30 mai 2025, 16:16 UTC

Actualités

S&P 500 Falls After Trump Hits Out at China -- WSJ

30 mai 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

30 mai 2025, 16:14 UTC

Actualités

HSBC Retreats From Banking Smaller U.S. Businesses -- WSJ

Comparaison

Variation de prix

Durect Corp prévision

Objectif de Prix

By TipRanks

843.4% hausse

Prévisions sur 12 Mois

Moyen 5 USD  843.4%

Haut 5 USD

Bas 5 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

2

Achat

1

Maintien

0

Vente

Éléments financiers

$

À Propos Durect Corp

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.